Home | Medical-Newswire.Com:
(Medical-NewsWire.com, November 14, 2017 ) Global point-of-care testing market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
Based on geography, the global point-of-care testing market is segmented into 5 geographical regions, such as,
Rest Of the World
Request a sample copy at http://www.reportsweb.com/inquiry&RW00011159388/sample
Global point-of-care testing market competition by top players including -
F. Hoffmann-La Roche Ltd is going to dominate the Point-Of-Care Testing market following with Siemens AG and Abbott Laboratories, Inc., along with others such as
Beckman Coulter, Inc.,
Becton, Dickinson and Company,
Johnson & Johnson, Alere Inc.,
PTS Diagnostics, Abaxis, Inc.,
Medtronic, Accriva Diagnostics,
OPTI Medical, Sienco, Inc.,
AccuBioTech Co., Ltd.,
ACON Laboratories, Inc.,
Atlas Genetics Ltd.,
Alfa Scientific Designs, Inc.,
Bio-Rad Laboratories, Inc.,
The global point-of-care testing market is segmented on the basis of product into prescription mode, distribution channel, end user, and geography.
On the basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Inquire for Report at http://www.reportsweb.com/inquiry&RW00011159388/buying
Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the market is segmented into direct tenders and retail.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal). Also, clinic is segmented into physicians' clinic and diagnostic clinic.
Siemens AG and Abbott Laboratories
along with others such as Beckman Coulter
Dickinson and Company
Johnson & Johnson
For more information about this report at http://www.reportsweb.com/global-point-of-care-testing-market-analysis-and-forecast-to-2024